Four Questions for the Energy and Commerce Hearing on 340B

Later this morning, the House Energy and Commerce Committee will hold a hearing to examine the rampant abuse within the 340B drug discount program. The 340B program was created by Congress in 1992, with the support of the biopharmaceutical industry, to help uninsured and financially vulnerable patients gain access to affordable prescription drugs. As part of the law, drug manufacturers provide steep discounts on outpatient medicines and treatments to select hospitals and other health care e